Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
+12.31%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$15.4B
AUM Growth
+$1.27B
(+9%)
Cap. Flow
-$48.9M
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
26.38%
Holding
2,849
New
208
Increased
1,406
Reduced
723
Closed
51
Top Buys
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$52.9M |
| 2 |
SPDR Gold Trust
GLD
|
+$41.1M |
| 3 |
Verizon
VZ
|
+$36.9M |
| 4 |
Micron Technology
MU
|
+$28.8M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$28.4M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$198M |
| 2 |
Comcast
CMCSA
|
+$33M |
| 3 |
US Bancorp
USB
|
+$22.6M |
| 4 |
Costco
COST
|
+$21.7M |
| 5 |
Walmart
WMT
|
+$16M |
Sector Composition
| 1 | Technology | 27.36% |
| 2 | Financials | 12.61% |
| 3 | Healthcare | 11.6% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLL
2126
DELISTED
Piedmont Lithium
PLL
| $4.66K | ﹤0.01% |
350
+150
| +75% | +$2K |
|
2127
Liberty Live Group Series C
LLYVK
$9.25B
| $4.65K | ﹤0.01% |
106
| – | – |
|
2128
Comstock Resources
CRK
$4.65B
| $4.64K | ﹤0.01% |
500
+50
| +11% | +$464 |
|
2129
Edgewise Therapeutics
EWTX
$1.55B
| $4.63K | ﹤0.01% |
254
+37
| +17% | +$675 |
|
2130
Eventbrite
EB
$261M
| $4.53K | ﹤0.01% |
827
-31
| -4% | -$170 |
|
2131
InnovAge Holding
INNV
$562M
| $4.53K | ﹤0.01% |
1,020
| – | – |
|
2132
ALX Oncology
ALXO
$62.7M
| $4.48K | ﹤0.01% |
402
+10
| +3% | +$111 |
|
2133
ICF International
ICFI
$1.77B
| $4.37K | ﹤0.01% |
29
+14
| +93% | +$2.11K |
|
2134
Codexis
CDXS
$219M
| $4.33K | ﹤0.01% |
1,240
+15
| +1% | +$52 |
|
2135
Masimo
MASI
$7.92B
| $4.26K | ﹤0.01% |
29
-3
| -9% | -$441 |
|
2136
Comtech Telecommunications
CMTL
$65.3M
| $4.25K | ﹤0.01% |
1,238
| – | – |
|
2137
Alignment Healthcare
ALHC
$3.26B
| $4.17K | ﹤0.01% |
840
-18
| -2% | -$89 |
|
|
RVNC
2138
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.1K | ﹤0.01% |
834
+124
| +17% | +$610 |
|
2139
American Well
AMWL
$106M
| $4.05K | ﹤0.01% |
250
+2
| +0.8% | +$32 |
|
2140
Sensata Technologies
ST
$4.59B
| $4.04K | ﹤0.01% |
110
+50
| +83% | +$1.84K |
|
2141
Fulgent Genetics
FLGT
$667M
| $4.02K | ﹤0.01% |
185
-5
| -3% | -$109 |
|
2142
Seadrill
SDRL
$2.02B
| $3.97K | ﹤0.01% |
79
+43
| +119% | +$2.16K |
|
2143
Mueller Water Products
MWA
$3.86B
| $3.94K | ﹤0.01% |
245
+128
| +109% | +$2.06K |
|
2144
Opko Health
OPK
$1.12B
| $3.93K | ﹤0.01% |
3,276
-23
| -0.7% | -$28 |
|
2145
Primoris Services
PRIM
$6.35B
| $3.92K | ﹤0.01% |
92
+43
| +88% | +$1.83K |
|
2146
Rentokil
RTO
$12.8B
| $3.92K | ﹤0.01% |
130
-36
| -22% | -$1.09K |
|
2147
Microvision
MVIS
$334M
| $3.9K | ﹤0.01% |
2,121
+330
| +18% | +$607 |
|
2148
EVgo
EVGO
$515M
| $3.79K | ﹤0.01% |
1,511
-5,249
| -78% | -$13.2K |
|
2149
ESAB
ESAB
$6.9B
| $3.76K | ﹤0.01% |
34
| – | – |
|
2150
Ultragenyx Pharmaceutical
RARE
$3.02B
| $3.74K | ﹤0.01% |
80
| – | – |
|